In conclusion, this contribution devised a smartphone-based portable PEC immunoassay for the determination of breast cancer biomarkers (human epidermal growth factor receptor 2; HER2) by coupling with the Co9S8@ZnIn2S4-modified SPE system. This evidence concerns the gene ERBB2 and breast carcinoma.